|
1
|
Malone FD, Canick JA, Ball RH, Nyberg DA,
Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo
SD, et al: First- and Second-Trimester Evaluation of Risk (FASTER)
Research Consortium: First-trimester or second-trimester screening,
or both, for Down's syndrome. N Engl J Med. 353:2001–2011. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Haddow JE, Palomaki GE, Knight GJ,
Williams J, Miller WA and Johnson A: Screening of maternal serum
for fetal Down's syndrome in the first trimester. N Engl J Med.
338:955–961. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nicolaides KH, Syngelaki A, Ashoor G,
Birdir C and Touzet G: Noninvasive prenatal testing for fetal
trisomies in a routinely screened first-trimester population. Am J
Obstet Gynecol. 207:374.e1–374.e6. 2012. View Article : Google Scholar
|
|
4
|
Tabor A and Alfirevic Z: Update on
procedure-related risks for prenatal diagnosis techniques. Fetal
Diagn Ther. 27:1–7. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wright CF and Burton H: The use of
cell-free fetal nucleic acids in maternal blood for non-invasive
prenatal diagnosis. Hum Reprod Update. 15:139–151. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
de Jong A, Dondorp WJ, de Die-Smulders
CEM, Frints SGM and de Wert GMWR: Non-invasive prenatal testing:
Ethical issues explored. Eur J Hum Genet. 18:272–277. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Norton ME, Brar H, Weiss J, Karimi A,
Laurent LC, Caughey AB, Rodriguez MH, Williams J III, Mitchell ME,
Adair CD, et al: Non-Invasive Chromosomal Evaluation (NICE) Study:
Results of a multicenter prospective cohort study for detection of
fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol.
207:137.e1–137.e8. 2012. View Article : Google Scholar
|
|
8
|
Mao J, Wang T, Wang BJ, Liu YH, Li H,
Zhang J, Cram D and Chen Y: Confined placental origin of the
circulating cell free fetal DNA revealed by a discordant
non-invasive prenatal test result in a trisomy 18 pregnancy. Clin
Chim Acta. 433:190–193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Garfield SS and Armstrong SO: Clinical and
cost consequences of incorporating a novel non-invasive prenatal
test into the diagnostic pathway for fetal trisomies. J Managed
Care Med. 15:34–41. 2012.
|
|
10
|
Wald NJ, George L, Smith D, Densem JW and
Petterson K: International Prenatal Screening Research Group: Serum
screening for Down's syndrome between 8 and 14 weeks of pregnancy.
Br J Obstet Gynaecol. 103:407–412. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liang D, Lv W, Wang H, Xu L, Liu J, Li H,
Hu L, Peng Y and Wu L: Non-invasive prenatal testing of fetal whole
chromosome aneuploidy by massively parallel sequencing. Prenat
Diagn. 33:409–415. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Garcia Gonzalez JR and Meza-Espinoza JP:
Use of the international system for human cytogenetic nomenclature
(ISCN). Blood. 108:3952–3953. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Alfirevic Z, Sundberg K and Brigham S:
Amniocentesis and chorionic villus sampling for prenatal diagnosis.
Cochrane Database Syst Rev. 1:1–142. 2009.
|
|
14
|
Lau TK, Jiang FM, Stevenson RJ, Lo TK,
Chan LW, Chan MK, Lo PSS, Wang W, Zhang HY, Chen F, et al:
Secondary findings from non-invasive prenatal testing for common
fetal aneuploidies by whole genome sequencing as a clinical
service. Prenat Diagn. 33:602–608. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Song Y, Liu C, Qi H, Zhang Y, Bian X and
Liu J: Noninvasive prenatal testing of fetal aneuploidies by
massively parallel sequencing in a prospective Chinese population.
Prenat Diagn. 33:700–706. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Verweij EJ, de Boer MA and Oepkes D:
Non-invasive prenatal testing for trisomy 13: More harm than good?
Ultrasound Obstet Gynecol. 44:112–114. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nicolaides KH, Spencer K, Avgidou K,
Faiola S and Falcon O: Multicenter study of first-trimester
screening for trisomy 21 in 75 821 pregnancies: Results and
estimation of the potential impact of individual risk-orientated
two-stage first-trimester screening. Ultrasound Obstet Gynecol.
25:221–226. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rozenberg P, Bussières L, Chevret S,
Bernard JP, Malagrida L, Cuckle H, Chabry C, Durand-Zaleski I,
Bidat L, Lacroix I, et al: Screening for Down syndrome using
first-trimester combined screening followed by second-trimester
ultrasound examination in an unselected population. Am J Obstet
Gynecol. 195:1379–1387. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yao H, Jiang F, Hu H, Gao Y, Zhu Z, Zhang
H, Wang Y, Guo Y, Liu L, Yuan Y, et al: Detection of fetal sex
chromosome aneuploidy by massively parallel sequencing of maternal
plasma DNA: Initial experience in a Chinese hospital. Ultrasound
Obstet Gynecol. 44:17–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Devers PL, Cronister A, Ormond KE, Facio
F, Brasington CK and Flodman P: Noninvasive prenatal
testing/noninvasive prenatal diagnosis: The position of the
National Society of Genetic Counselors. J Genet Couns. 22:291–295.
2013. View Article : Google Scholar : PubMed/NCBI
|
